• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中线粒体基因组的点突变

Point mutations of mitochondrial genome in Parkinson's disease.

作者信息

Ikebe S, Tanaka M, Ozawa T

机构信息

Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.

出版信息

Brain Res Mol Brain Res. 1995 Feb;28(2):281-95. doi: 10.1016/0169-328x(94)00209-w.

DOI:10.1016/0169-328x(94)00209-w
PMID:7723627
Abstract

Oxidative stress and subsequent energy crisis have been proposed as the cause of nigral neuronal cell death in Parkinson's disease. We have reported defects in the mitochondrial respiratory chain and increased amount of deleted mitochondrial genome in the nigrostriatal system of patients with Parkinson's disease. Deletion in mitochondrial DNA could be ascribed to somatically acquired premature aging leading to cell death. To elucidate the contribution of maternally transmitted point mutations in mitochondrial DNA to the premature DNA damages, we employed a direct sequencing system and analyzed the total nucleotide sequences of mitochondrial DNA in the brains of five patients with idiopathic Parkinson's disease. There were no predominant point mutations among the patients in contrast to some neuromuscular diseases. However, each patient had several point mutations that would result in a significant change in the gene products. Some of these mutations may be involved either in the increased production of oxygen radicals from the mitochondrial respiratory chain or in the increased susceptibility of the respiratory chain components to oxidative damage. We propose that some of these mutations can be regarded as one of the risk factors accelerating degeneration of nigrostriatal pathway in Parkinson's disease.

摘要

氧化应激及随后的能量危机被认为是帕金森病黑质神经元细胞死亡的原因。我们曾报道帕金森病患者黑质纹状体系统存在线粒体呼吸链缺陷以及缺失型线粒体基因组数量增加。线粒体DNA的缺失可能归因于体细胞获得性早衰,进而导致细胞死亡。为阐明线粒体DNA母系传递的点突变对DNA过早损伤的作用,我们采用直接测序系统,分析了5例特发性帕金森病患者大脑中线粒体DNA的全核苷酸序列。与某些神经肌肉疾病不同,这些患者中没有占主导地位的点突变。然而,每位患者都有几个点突变,这些突变会导致基因产物发生显著变化。其中一些突变可能与线粒体呼吸链氧自由基生成增加有关,或者与呼吸链成分对氧化损伤的易感性增加有关。我们认为,这些突变中的一些可被视为加速帕金森病黑质纹状体通路退变的危险因素之一。

相似文献

1
Point mutations of mitochondrial genome in Parkinson's disease.帕金森病中线粒体基因组的点突变
Brain Res Mol Brain Res. 1995 Feb;28(2):281-95. doi: 10.1016/0169-328x(94)00209-w.
2
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.线粒体 DNA 缺失在多巴胺能神经元内的积累引发神经保护机制。
Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196.
3
Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.泛醌(辅酶Q10)与帕金森病氧化应激中的线粒体
Biol Signals Recept. 2001 May-Aug;10(3-4):224-53. doi: 10.1159/000046889.
4
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease.衰老及帕金森病患者大脑皮质和黑质中的体细胞线粒体DNA突变
Neurobiol Aging. 2004 Jan;25(1):71-81. doi: 10.1016/s0197-4580(03)00037-x.
5
Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.聚合酶γ突变患者的严重黑质纹状体变性而无临床帕金森病。
Brain. 2013 Aug;136(Pt 8):2393-404. doi: 10.1093/brain/awt103. Epub 2013 Apr 26.
6
Absence of the mitochondrial A7237T mutation in Parkinson's disease.帕金森病中线粒体A7237T突变缺失。
Biochem Biophys Res Commun. 1995 Jun 15;211(2):700-4. doi: 10.1006/bbrc.1995.1868.
7
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].帕金森病的病因与发病机制:从线粒体功能障碍到家族性帕金森病
Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62.
8
Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease.在帕金森病中对神经元线粒体缺失进行超深度图谱绘制。
Neurobiol Aging. 2018 Mar;63:120-127. doi: 10.1016/j.neurobiolaging.2017.10.024. Epub 2017 Dec 8.
9
Sequence analysis of the entire mitochondrial genome in Parkinson's disease.帕金森病患者线粒体全基因组序列分析
Biochem Biophys Res Commun. 2002 Feb 8;290(5):1593-601. doi: 10.1006/bbrc.2002.6388.
10
Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence.帕金森病和衰老过程中纹状体中线粒体DNA缺失增加。
Biochem Biophys Res Commun. 1990 Aug 16;170(3):1044-8. doi: 10.1016/0006-291x(90)90497-b.

引用本文的文献

1
Monogenic Disorders of ROS Production and the Primary Anti-Oxidative Defense.单基因氧化还原产物异常和主要抗氧化防御异常。
Biomolecules. 2024 Feb 9;14(2):206. doi: 10.3390/biom14020206.
2
Acceleration of the Deamination of Cytosine through Photo-Crosslinking.通过光交联加速胞嘧啶脱氨作用
Curr Issues Mol Biol. 2023 May 29;45(6):4687-4700. doi: 10.3390/cimb45060298.
3
Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease.靶向线粒体作为帕金森病的一种治疗方法。
Cell Mol Neurobiol. 2023 May;43(4):1499-1518. doi: 10.1007/s10571-022-01265-w. Epub 2022 Aug 11.
4
A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models.摇摇欲坠的基因组:通过强调使用杂种细胞模型来探索线粒体 DNA 完整性对帕金森病的影响。
Cell Mol Life Sci. 2022 May 5;79(5):283. doi: 10.1007/s00018-022-04304-3.
5
Understanding the Multiple Role of Mitochondria in Parkinson's Disease and Related Disorders: Lesson From Genetics and Protein-Interaction Network.了解线粒体在帕金森病及相关疾病中的多重作用:来自遗传学和蛋白质相互作用网络的启示
Front Cell Dev Biol. 2021 Apr 1;9:636506. doi: 10.3389/fcell.2021.636506. eCollection 2021.
6
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.线粒体在神经退行性疾病中的作用:阿尔茨海默病和帕金森病的启示。
Mol Neurobiol. 2020 Jul;57(7):2959-2980. doi: 10.1007/s12035-020-01926-1. Epub 2020 May 22.
7
Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Mitochondrial DNA Profiling of Parkinson's Disease.生物复杂性和分形在衰老和病理学生物标志物搜索中的应用:帕金森病的线粒体 DNA 分析。
Int J Mol Sci. 2020 Mar 4;21(5):1758. doi: 10.3390/ijms21051758.
8
The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.线粒体 DNA 在帕金森病中的未解决作用:已发表研究的概述、其局限性及未来展望。
Neurochem Int. 2019 Oct;129:104495. doi: 10.1016/j.neuint.2019.104495. Epub 2019 Jun 21.
9
Mitochondrial Targeting in Neurodegeneration: A Heme Perspective.神经退行性疾病中的线粒体靶向:血红素视角
Pharmaceuticals (Basel). 2018 Sep 18;11(3):87. doi: 10.3390/ph11030087.
10
Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson's Disease Penetrance.影响线粒体健康和帕金森病外显率的环境与遗传变量
Parkinsons Dis. 2018 Mar 7;2018:8684906. doi: 10.1155/2018/8684906. eCollection 2018.